NCT04260022 2025-11-05Study of HQP1351 in Subjects With Refractory CML and Ph+ ALLAscentage Pharma Group Inc.Phase 1 Recruiting242 enrolled
NCT02730312 2022-03-08PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesXencor, Inc.Phase 1 Completed120 enrolled
NCT01474681 2020-12-30Safety and Tolerability of HSC835 in Patients With Hematological MalignanciesNovartisPhase 1/2 Completed27 enrolled 15 charts
NCT02431260 2019-06-14An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated69 enrolled 34 charts
NCT00891137 2014-10-27Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCellerant TherapeuticsPhase 1 Completed30 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00886496 2012-06-20Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaEnzon Pharmaceuticals, Inc.Phase 1 Withdrawn